Butterfly Network (BFLY) Depreciation & Amortization (CF) (2020 - 2026)
Butterfly Network (BFLY) reported Depreciation & Amortization (CF) of $1.8 million for Q1 2026, down 23.26% on a YoY basis from $2.4 million in Q1 2025, and up 3.25% sequentially from $1.8 million in Q4 2025.
Butterfly Network (BFLY) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
Butterfly Network (BFLY) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $1.8 million in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 23.26% year-over-year to $1.8 million; the trailing twelve-month figure through Mar 2026 stood at $7.5 million (down 25.56% YoY), and the FY2025 full-year result was $8.1 million, down 21.86% from the prior year.
- Depreciation & Amortization (CF) advanced to $1.8 million in Q1 2026, from $1.8 million in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $4.0 million in Q3 2023 to a low of $839000.0 in Q1 2022.
- A 5-year average of $2.2 million and a median of $2.1 million in 2023 frame the typical range for Depreciation & Amortization (CF).
- Across the five-year window, Depreciation & Amortization (CF) surged 271.49% in 2022 and tumbled 34.99% in 2024, its largest moves.
- Tracing BFLY's Depreciation & Amortization (CF) over 5 years: stood at $1.9 million in 2022, then rose by 19.96% to $2.2 million in 2023, then advanced by 11.82% to $2.5 million in 2024, then slumped by 30.04% to $1.8 million in 2025, then gained by 3.25% to $1.8 million in 2026.
- Business Quant data shows BFLY's Depreciation & Amortization (CF) at $1.8 million in Q1 2026, $1.8 million in Q4 2025, and $1.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 67.10 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 78.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 310.25 Mn |
| 10 | Butterfly Network | 1.79 Bn | 1.65 Bn | 18.29 Mn | 1.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.81 Mn |
| Mar 31, 2026 | 1.81 Mn |
| Dec 31, 2025 | 1.75 Mn |
| Dec 31, 2025 | 1.75 Mn |
| Sep 30, 2025 | 1.89 Mn |
| Sep 30, 2025 | 1.89 Mn |
| Jun 30, 2025 | 2.08 Mn |
| Jun 30, 2025 | 2.08 Mn |
| Mar 31, 2025 | 2.36 Mn |
| Mar 31, 2025 | 2.36 Mn |
| Dec 31, 2024 | 2.51 Mn |
| Dec 31, 2024 | 2.51 Mn |
| Sep 30, 2024 | 2.62 Mn |
| Sep 30, 2024 | 2.62 Mn |
| Jun 30, 2024 | 2.63 Mn |
| Jun 30, 2024 | 2.63 Mn |
| Mar 31, 2024 | 2.58 Mn |
| Mar 31, 2024 | 2.58 Mn |
| Dec 31, 2023 | 2.24 Mn |
| Dec 31, 2023 | 2.24 Mn |